Your browser doesn't support javascript.
loading
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.
Shoham, Shmuel; Bloch, Evan M; Casadevall, Arturo; Hanley, Daniel; Lau, Bryan; Gebo, Kelly; Cachay, Edward; Kassaye, Seble G; Paxton, James H; Gerber, Jonathan; Levine, Adam C; Naeim, Arash; Currier, Judith; Patel, Bela; Allen, Elizabeth S; Anjan, Shweta; Appel, Lawrence; Baksh, Sheriza; Blair, Paul W; Bowen, Anthony; Broderick, Patrick; Caputo, Christopher A; Cluzet, Valerie; Cordisco, Marie Elena; Cruser, Daniel; Ehrhardt, Stephan; Forthal, Donald; Fukuta, Yuriko; Gawad, Amy L; Gniadek, Thomas; Hammel, Jean; Huaman, Moises A; Jabs, Douglas A; Jedlicka, Anne; Karlen, Nicky; Klein, Sabra; Laeyendecker, Oliver; Lane, Karen; McBee, Nichol; Meisenberg, Barry; Merlo, Christian; Mosnaim, Giselle; Park, Han-Sol; Pekosz, Andrew; Petrini, Joann; Rausch, William; Shade, David M; Shapiro, Janna R; Singleton, J Robinson; Sutcliffe, Catherine.
Afiliação
  • Shoham S; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Bloch EM; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Casadevall A; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Hanley D; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Lau B; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Gebo K; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Cachay E; Department of Medicine, Division of Infectious Diseases, University of California, San Diego, San Diego, California, USA.
  • Kassaye SG; Division of Infectious Diseases/Department of Medicine, Georgetown University Medical Center, Washington D.C, USA.
  • Paxton JH; Department of Emergency Medicine, Wayne State University, Detroit, Michigan, USA.
  • Gerber J; Department of Medicine, Division of Hematology and Oncology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Levine AC; Department of Emergency Medicine, Rhode Island Hospital/Brown University, Providence, Rhode Island, USA.
  • Naeim A; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California, USA.
  • Currier J; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California, USA.
  • Patel B; Department of Medicine, Division Critical Care Medicine, University of Texas Health, Houston, Texas, USA.
  • Allen ES; Department of Pathology, University of California, San Diego, San Diego, California, USA.
  • Anjan S; Department of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Appel L; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Baksh S; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Blair PW; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Bowen A; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Broderick P; Department of Emergency Medicine, Danbury Hospital, Danbury, Connecticut, USA.
  • Caputo CA; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Cluzet V; Vassar Brothers Medical Center, Nuvance Health, Poughkeepsie, New York, USA.
  • Cordisco ME; Office of Clinical Trials, Nuvance Health, University of Vermont, Danbury, Connecticut, USA.
  • Cruser D; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Ehrhardt S; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Forthal D; Department of Medicine, Division of Infectious Diseases, University of California, Irvine, Irvine, California, USA.
  • Fukuta Y; Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA.
  • Gawad AL; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Gniadek T; Department of Pathology, Northshore University Health System, Evanston, Illinois, USA.
  • Hammel J; Department of Emergency Medicine, Norwalk Hospital, Norwalk, Connecticut, USA.
  • Huaman MA; Department of Medicine, Division of Infectious Diseases, University of Cincinnati, Cincinnati, Ohio, USA.
  • Jabs DA; Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Jedlicka A; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Karlen N; Mosaic Consulting Ltd., Israel.
  • Klein S; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Laeyendecker O; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, USA.
  • Lane K; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • McBee N; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Meisenberg B; Department of Medicine, Luminis Health, Annapolis, Maryland, USA.
  • Merlo C; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Mosnaim G; Division of Allergy and Immunology, Department of Medicine, Northshore University Health System, Evanston, Illinois, USA.
  • Park HS; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Pekosz A; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Petrini J; Office of Clinical Trials, Nuvance Health, University of Vermont, Danbury, Connecticut, USA.
  • Rausch W; Office of Clinical Trials, Nuvance Health, University of Vermont, Danbury, Connecticut, USA.
  • Shade DM; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Shapiro JR; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Singleton JR; Department of Neurology, University of Utah, Salt Lake City, Utah, USA.
  • Sutcliffe C; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Clin Infect Dis ; 76(3): e477-e486, 2023 02 08.
Article em En | MEDLINE | ID: mdl-35579509
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos